Imipramine kunye nezinye iindidi zeMida ye-ADHD

ABASEBENZI ABASEBENZI

Umntwana wam uthatha imipramine kwi-ADHD, kwaye andizange ndive ngaye nabani na othabatha le nyilisi ye-ADHD ngaphambili. Unyana wam oneminyaka eyi-16 uye wafika. Use-Adderall XR. Ndisebenzisana ne-ADD iminyaka kwaye ndandicinga ukuba umntwana wam unamayeza afanelekileyo kuba unina uthi uyindawo yokulala. Ngaba kunjalo?

Nangona i-imipramine ayithathwa njengemichiza yokuqala yomgca okanye ukhetho lokuqala oluqhelekileyo logqirha xa unyanga umntwana nge-ADHD, isenokusetyenziswa.

Ngokwezikhokelo ze- ADHD ezivela kwi-American Academy ye-Pediatrics kunye ne-American Academy of Child kunye ne-Adolescent Psychiatry, imithi yokuqala engasetyenziswa ekuphatheni abantwana abane-ADHD ibandakanya ukuvuselela, njengoRitalin no-Adderall, kunye nemithi emitsha engeyiyo imvuselelo.

Iifom zeRitalin ze-ADHD

Kukho iindidi ezininzi zeemethylphenidate okanye iRitalin, eziquka imfutshane (kabini ngosuku) kunye nokulungiselela ixesha elide (kanye kanye ngosuku). Ezinye iifom ezikhoyo ziquka:

Ngaphandle kwamachiza amasha, uStatrana, u-Quillichew ER, no-Quillivant XR, ezininzi zinokufumaneka kwiifom zendalo.

Iifomu ze-Amphetamine kwi-ADHD

Ama-stimulants ase-Amphetamine nawo afumaneka kwiifom ezahlukeneyo, kubandakanya i-short-acting (iphindwe kabini ngosuku) kunye nefom yexesha elide (kanye ngosuku), kuquka:

Ngaphandle kwamachiza amasha, i-Adzenys XR ODT kunye neVavse, ezininzi zinokufumaneka kwiifom zendalo.

Ukungenzi izikhuthazo ze-ADHD

Ukongeza kwimishanguzo evuselelayo, kukho ezinye iindlela ezingenakuvuselela ukuphatha i-ADHD ngoku, kuquka:

I-Strattera ayifumanekanga njengesizukulwana.

I-Second Line ADHD

Amachiza asemibini okanye eminye indlela eya kukhuthaza kunye ne-Strattera ngokuqhelekileyo zibandakanya i-anti-depressants, njenge-bupropion (Welbutrin), imipramine (eTofranil), ne-Nortriptyline (Pamelor), kunye ne-alpha-2-adrenergic agonists, njenge-clonidine (Catapres) kunye ne-guanfacine (iTenex ).

Ngokuqhelekileyo, oogqirha badla ngokuya kumachiza omgca wesibini xa umntwana engaphumeleli okanye engayinyamezelanga imithi emibini okanye ngaphezulu.

Ngokuvunyelwa kwe-FDA yeKapvay kunye ne-Intuniv ukunyanga abantwana abane-ADHD, i-American Academy ye-Pediatrics izikhokelo zamanje aziqwalaselanga imida yesibini ye-ADHD, endaweni yoko ithi:

Iingcebiso zakutshanje ezivela kwi-American Academy of Child kunye ne-Adolescent Psychiatry, ukususela ngo-2007, usacacisa ukuba "ukuba akukho nanye wabasebenzi abangasentla abangela unyango olwanelisayo lwesigulane nge-ADHD, ugqirha kufuneka ahlolisise ngokuchanekileyo ukuxilongwa kwaye acinge unyango wokuziphatha kunye / okanye ukusetyenziswa kwamachiza angavunywanga yi-FDA kunyango lwe-ADHD. " Esi siphakamiso sishiya indawo evulelekileyo ukuzama amayeza afana ne-Wellbutrin kunye neMipramine, njl.

Ingaba i-stepon yakho yonyango efanelekileyo kwi-ADHD?

Oku kuxhomekeke kwindlela ayenzileyo ngayo. Ukuba iimpawu zakhe ze-ADHD ziphantsi kolawulo olufanelekileyo kwaye akanalo naluphi na umphumo, kwaye mhlawumbi unamachiza afanelekileyo, nangona ukuba akuyona imida okanye "imigca yokuqala" ye-ADHD. Ukuba ayenzi kakuhle, ngoko kufuneka ukhulume nomntwana wezilwanyana malunga nokulungelelanisa umthamo wakhe okanye ucinge ngamachiza ahlukeneyo.

Ewe, i-imipramine isetyenziselwa ukuphatha abantwana ngokulala, ngokubhekiselele ekuphatheni uxinzelelo kunye nezinye iimeko.

Into yokugqibela ukuyiqwalasela ukuba ukuba 'iimpawu zakhe ze-ADHD' zilungele imipramine kwaye akazange enze kakuhle ngokukhuthaza, mhlawumbi wayexinezelekile kwindawo yokuqala kwaye akazange abe ne-ADHD. Akunakwenzeka ukwenza isigqibo sangempela njengaye ngaphandle kolwazi oluninzi kunye novavanyo olusisiseko, kodwa into ecinga ngayo.

> Imithombo:

> I-American Academy ye-Pediatrics Guideline Practice Guideline. I-ADHD: Isikhokelo seNkcazo yokuSebenza, ukuVavanya kunye nokuPhathwa kweNkcazo-Ukulahleka / ukuxhatshazwa kwengxaki kwi-Children and Adolescents. Pediatrics. 108 (4): 1033.

> I-American Academy Yomntwana kunye ne-Adolescent Psychiatry. Yenza iParamameter yoVavanyo kunye noNyango lwaBantwana kunye ne-Adolescents nge-Attention-Deficit / Hyperactivity Disorder. J. AM. I-ACAD. CHILDADOLESC. I-PSYCHIATRY, 46: 7, JULY 2007